The Entourage Effect: A Deep Dive

What the entourage effect actually claims

At its simplest, the entourage effect is the idea that the compounds in hemp and cannabis do more — or something different — together than any one of them does alone. In particular, that terpenes shape and color the experience cannabinoids provide, rather than just riding along for the smell.

It’s worth being precise about what that does and doesn’t say. The claim is about interaction — that the mix behaves differently from the parts added up. It is not a claim that any single compound treats or cures anything, and it is not one tidy, proven mechanism. “Entourage effect” is really an umbrella over several possible kinds of interaction: one compound changing how much of another reaches your system, compounds acting on different targets that add up, or compounds nudging the same target in different directions.

Hold on to that distinction. A lot of the confusion around this topic comes from treating “the entourage effect” as a single settled fact, when it’s better understood as a family of related, still-developing hypotheses.

Where the idea came from

The phrase “entourage effect” was introduced in 1998 by Shimon Ben-Shabat and Raphael Mechoulam — the Israeli chemist whose lab first isolated THC decades earlier. Their paper wasn’t about terpenes at all. They found that certain molecules the body makes, ones that were inactive on their own, could still boost the activity of an endocannabinoid the body produces. Inactive parts, meaningful whole. That was the original “entourage” — an effect among the body’s own compounds, not plant terpenes (Ben-Shabat et al., 1998).

The version most people mean today — that terpenes and cannabinoids work together — was laid out most influentially by the neurologist and researcher Ethan Russo in a 2011 review titled “Taming THC.” Russo gathered the scattered evidence on individual terpenes and proposed, carefully and explicitly as a hypothesis, that terpenoids could meaningfully modulate the effects of cannabinoids. That paper is where much of the modern conversation starts — and it’s worth reading as a set of well-argued proposals, not a list of proven results (Russo, 2011).

What the evidence does and doesn’t show

This is the honest core of the page, so we’ll take it slowly. Most of the strongest evidence for compounds working together comes from preclinical work — cells in a dish and studies in mice — not from large, well-controlled human trials. Preclinical results are how good hypotheses get built, but they don’t automatically carry over to what you feel from a bottle.

The evidence also cuts both ways, and we think that’s important to show rather than hide. On the supportive side, a 2021 study led by researchers at the University of Arizona reported that several cannabis terpenes produced cannabinoid-like behaviors in mice and could add to the activity of a laboratory cannabinoid compound (WIN55,212-2) — an additive effect, not proven synergy, and not a study of THC (LaVigne et al., 2021). On the skeptical side, a 2020 study found that common cannabis terpenes did not directly change signaling at the main cannabinoid receptors, suggesting that if terpenes do shape the experience, they may do it through other routes than the obvious one (Finlay et al., 2020).

Pulling back to the whole field, a 2024 narrative scoping review in Cannabis and Cannabinoid Research looked across the literature and concluded that the evidence for the entourage effect is still limited and inconclusive, and urged caution about treating it as an established fact (Simei et al., 2024). That is roughly where we sit too: there’s enough signal to make the hypothesis genuinely interesting, and not yet enough to call it proven.

Terpenes, in plain terms

Terpenes are the aromatic molecules that give plants their smell and character. They aren’t exotic or cannabis-specific — they’re everywhere. Linalool is the calm, floral note in lavender. Limonene is the bright lift in citrus peel. Myrcene is the heavy, earthy one you can smell in mango and hops. Beta-caryophyllene is the peppery bite in black pepper and cloves.

How they might act is an open and genuinely interesting question. Beta-caryophyllene is the clearest case: research published in 2008 showed it selectively binds one of the body’s cannabinoid receptors (CB2) and acts on it, which is unusual for a dietary plant molecule and is why it’s sometimes described as a “dietary cannabinoid” (Gertsch et al., 2008). Most other terpenes don’t appear to work that neatly, and the proposed routes — effects on other receptors, on how compounds are absorbed, or simply on mood through smell — are still being worked out.

The practical takeaway isn’t a mechanism — it’s that these are real, characterful molecules with distinct personalities you can already recognize from your kitchen and garden. That everyday familiarity is exactly what makes them a good place to start paying attention.

The role of THC — and why it clouds what you feel

THC is powerful on its own. That’s exactly why it’s a problem for learning. When THC is in the mix, its intoxication tends to dominate the experience — and it can drown out or muddy your sense of what a single terpene is actually doing. Add a terpene on top of a strong THC effect and, yes, the whole thing will feel stronger and different; but you’ll have a hard time telling which part of that shift was the terpene and which was just more THC.

Here’s a small piece of proof that terpenes carry real weight without any THC involved: our Myrcene drops are notably strong on their own — heavy and unmistakable — even though there’s no intoxicant in them. That’s a useful demonstration that a terpene isn’t a bystander. None of this is a knock on THC. It’s just that if your goal is to understand a variable, you turn the loudest one down first.

Why we study terpenes in relative isolation

“Relative isolation” is the whole methodology in two words. If you want to learn what one terpene does for your body, the cleanest way is to feel it with as few competing variables as possible: a single terpene, paired with high-purity CBD, and no THC to confound the signal. Change one thing at a time and you can actually attribute what you notice.

We call it relative isolation on purpose. A terpene with CBD isn’t a single molecule in a vacuum — it’s a small, deliberate combination. But it’s a far simpler starting point than a full-spectrum blend with a dozen moving parts, and simplicity is what makes learning possible. This is the opposite of how most of the industry works, and it’s a deliberate choice. See why we break it apart on the main page.

CBD as a second, lower-weighted variable

CBD is a variable too — it’s part of every pairing — but in our experience it changes a terpene’s character far less than THC does. THC is the loud one; CBD is closer to the steady base you build on. It’s not intoxicating and it doesn’t take over the experience the way THC can, which is exactly why it works well as the constant background while the terpene is the thing you’re actually paying attention to. Keeping the base consistent from one drop to the next is what lets the terpene be the difference you feel.

A framework for exploring on your own

Here’s a simple, unhurried way to approach it. There’s no rush and no single right answer — the point is to notice.

1. Find your baseline in relative isolation. Try one terpene — paired with high-purity CBD, no THC — on its own, on a calm day, and simply pay attention to what you notice.
2. Get to know a few, one at a time. Linalool one day, Myrcene another. Give each one a fair, separate try before you start comparing them.
3. Then reintroduce variables, on purpose. Once you know your baseline, add THC from whatever source suits you — flower, an edible, a beverage, a vape, or a dab — and watch how the picture shifts.
4. Tune the terpene on top. Pair a drop with your favorite strain to amplify a chosen terpene — add Myrcene to a session, for instance — and notice how it colors the experience compared with your baseline.

To be plain about it: mixing our drops with your own cannabis is not just allowed, it’s a great way to explore once you have a baseline. The only reason we suggest starting without THC is so your first impression is clean — after that, the combinations are yours to play with.

What we still don’t know

Plenty. We don’t know exactly how most terpenes act in the body at the amounts found in real products. We don’t have large human trials cleanly separating a terpene’s contribution from everything else in a formula. We don’t know how much of what people report is a direct pharmacological effect versus the very real influence of aroma, expectation, and setting — all of which genuinely shape an experience.

We don’t treat that uncertainty as a weakness to paper over. It’s the reason the whole approach makes sense. While the field works out the general answers, the one thing you can study rigorously is your own response — one terpene at a time, in relative isolation, paying honest attention. Being upfront about the unknown isn’t a hedge; it’s the point.

References

These are the primary sources and reviews behind the claims above. They describe research, not medical advice.

1. Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology. 1998;353(1):23–31. doi.org/10.1016/S0014-2999(98)00392-6
2. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology. 2011;163(7):1344–1364. doi.org/10.1111/j.1476-5381.2011.01238.x
3. LaVigne JE, Hecksel R, Keresztes A, Streicher JM. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports. 2021;11:8232. doi.org/10.1038/s41598-021-87740-8
4. Finlay DB, Sircombe KJ, Nimick M, Jones C, Glass M. Terpenoids from cannabis do not mediate an entourage effect by acting at cannabinoid receptors. Frontiers in Pharmacology. 2020;11:359. doi.org/10.3389/fphar.2020.00359
5. Simei JLQ, Souza JDR, Lisboa JR, Campos AC, Guimarães FS, Zuardi A, Crippa JAS. Does the “entourage effect” in cannabinoids exist? A narrative scoping review. Cannabis and Cannabinoid Research. 2024;9(5):1202–1216. doi.org/10.1089/can.2023.0052
6. Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A. Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences (PNAS). 2008;105(26):9099–9104. doi.org/10.1073/pnas.0803601105